Gabe Musso, Chief Scientific Officer will be leading a presentation on how BioSymetrics is redefining AI-based Drug Discovery during the MedTech Showcase at #JPM2020. Topics will include how phenotype prediction can increase certainty of compound effects in vivo, identify off-target effects, reduce toxicity and shorten the path to market. Or click here to contact us/schedule a meeting.
Artificial Intelligence and Machine Learning (Episode 214) Dr. Kevin Folta discusses how the genomics era has generated tremendous data sets, yet the information they reveal is limited by the human biases that search them. Are there ways to examine complex data sets for hidden patterns that can unearth new perspectives in biology? This is the role of machine learning, and the patterns form the basis of artificial intelligence that then executes new tasks. While these
The Business of Healthcare Podcast, Episode 48: Artificial Intelligence and Machine Learning for Healthcare Anthony Iacovone, Chairman of BioSymetrics, joins host Dr. Bob Kaiser for a discussion about what biomedical artificial intelligence and machine learning are and how they can be used to improve outcomes in the areas of drug discovery, clinical diagnostics and value-based care as well as reduce healthcare costs. The Business of Healthcare is a twice-monthly podcast from the Center for Healthcare
The latest episode of Talking Precision Medicine podcast, our own Gabe Muso, speaks with Rafael Rosengarten CEO of Genialis on the practice of improving data preprocessing for the advancement of machine learning in medicine.